- Ionty železa jako "most" mezi nádorovým bujením, buněčným cyklem, kardiotoxicitou a Friedrichovou ataxiíPublication without faculty affiliation
- Cardiotoxicity of antitumourous treatment2004 | First Faculty of Medicine
- Cardiotoxicity and the role of cardiomarkers in her diagnosis2017 | Faculty of Medicine in Hradec Králové
- New iron chelators in anthracycline-induced cardiotoxicity2007 | Publication without faculty affiliation
- Cardiotoxicity - current guidelines2017 | Faculty of Medicine in Hradec Králové
- Cardiotoxicity - basic terms and mechanisms2017 | Faculty of Medicine in Hradec Králové
- MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity2019 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Pharmacological cardioprotection with iron chelators and anthracycline cardiotoxicity +1Publication without faculty affiliation
- Cardiotoxicity of cancer therapy2011 | First Faculty of Medicine
- Trastuzumab-induced cardiotoxicity: a review2023 | Third Faculty of Medicine
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo2008 | Central Library of Charles University
- Troponins as markers of some types of drug-induced cardiotoxicity2014 | Faculty of Medicine in Hradec Králové
- Acute cardiotoxicity - clinical presentation2016 | Faculty of Medicine in Hradec Králové
- Biomarkers for the early detection of anthracycline-induced cardiotoxicity: current status2014 | Faculty of Medicine in Hradec Králové
- Oral administration of quercetin is unable to protect against isoproterenol cardiotoxicity2014 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Evaluation of cardiotoxicity of oncology treatment - comparison of WHO and NCI classification +12009 | Publication without faculty affiliation
- Assessment of anthracycline-induced cardiotoxicity with biochemical markers2007 | First Faculty of Medicine
- Cardiotoxicity of anti-cancer drugs in experimental settings2017 | Faculty of Medicine in Hradec Králové
- Cardiotoxicity of antitumor drugs in ovarian cancer patients2015 | Faculty of Medicine in Hradec Králové
- Monitoring of cardiotoxicity of chemotherapy by means of cardiac troponins and echocardiography2008 | Faculty of Medicine in Hradec Králové
- Monitoring of cardiotoxicity of chemotherapy by means of cardiac troponins and echocardiography2008 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Monitoring of cardiotoxicity of chemotherapy by means of cardiac troponins and echocardiography2008 | First Faculty of Medicine
- Proteomic insights into chronic anthracycline cardiotoxicity2011 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- The Use Biochemical Markers in Cardiotoxicity Monitoring in Patients Treated for Leukemia2005 | First Faculty of Medicine
- Biomarkers of cardiac injury in detection of cardiotoxicity induced by chemotherapeutic agents2011 | Faculty of Medicine in Hradec Králové
- Anthracycline cardiotoxicity - mechanisms of development and pharmacological cardioprotectionPublication without faculty affiliation
- Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity2008 | First Faculty of Medicine
- Cardiotoxicity of anticancer treatment in patients with ovarian cancer2017 | Faculty of Medicine in Hradec Králové